Markets.com Logo

INMB

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.3491$
  • Previous Close
    2.3491$
  • 52 Week Change
    8.61$
  • Day Range
    0.00$
  • 52 Week High/Low
    1.89$ - 10.5$
  • Dividend Per Share
    --
  • Market cap
    62 475 K$
  • EPS
    -0.341
  • Beta
    0.978
  • Volume
    --

About

INMB.US represents Inmune Bio Inc., a clinical-stage biotechnology company focused on developing therapies that harness the innate immune system to fight disease. Their primary focus is on developing and commercializing products to treat cancer and neurological diseases, including Alzheimer's disease. Their lead product candidate, XPro1595, is a soluble TNF inhibitor being developed for Alzheimer's and other neurodegenerative conditions. The company is also pursuing other therapies targeting the innate immune system to treat cancer.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

[Company Performance]: Revenue growth, profitability, and successful clinical trial results can drive investor confidence and increase stock price.

[Market Sentiment]: Overall investor optimism or pessimism towards biotechnology stocks and the broader market influences demand and stock price.

[Regulatory Environment]: FDA approvals, changes in healthcare policies, and patent protection affect the company's potential market and investor perception.

[Competition]: Competitor's success, new therapies, and market share impact Inmune Bio's growth prospects and stock price.

[Economic Conditions]: Economic growth or recession, interest rates, and inflation affect investment decisions and overall market valuation.

[News & Events]: Announcements of clinical trial data, partnerships, mergers, and acquisitions affect investor reaction and stock price movement.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--